Midatech Pharma Plc
(LSE) MTPH
Midatech Pharma Plc Financials at a Glance
Market Cap
N/A
Revenue (TTM)
$381.00K
Net Income (TTM)
$12.81M
EPS (TTM)
N/A
P/E Ratio
N/A
Dividend
N/A
Beta (Volatility)
N/A
Dividend
N/A
Beta (Volatility)
N/A
Price
N/A
Volume
N/A
Open
N/A
Price
N/A
Volume
N/A
Open
N/A
Previous Close
N/A
Daily Range
N/A
52-Week Range
N/A
Dividend
N/A
Beta (Volatility)
N/A
Price
N/A
Volume
N/A
Open
N/A
Previous Close
N/A
Daily Range
N/A
52-Week Range
N/A
MTPH News
Motley Fool Moneyball Superscore
Our CEO Is Handing Members His Secret Weapon
It's called Motley Fool Moneyball, our new proprietary AI tool
We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.
Get Access NowAbout Midatech Pharma Plc
Industry
Biotechnology
Sector
Health CareEmployees
13
CEO
Stephen Anthony Stamp
Website
www.biodexapharma.comHeadquarters
Cardiff, CF10 4DQ, GB
MTPH Financials
Key Financial Metrics (TTM)
Gross Margin
0%
Operating Margin
0%
Net Income Margin
0%
Return on Equity
-56%
Return on Capital
-73%
Return on Assets
-35%
Earnings Yield
N/A
Dividend Yield
0.00%
Payout Ratio
0.00%
Stock Overview
Market Cap
N/A
Shares Outstanding
N/A
Volume
N/A
Short Interest
N/A
Avg. Volume
N/A
Financials (TTM)
Gross Profit
$5.44M
Operating Income
$9.20M
EBITDA
$9.08M
Operating Cash Flow
$12.26M
Capital Expenditure
$774.00K
Free Cash Flow
$13.04M
Cash & ST Invst.
$1.67M
Total Debt
$727.00K
Midatech Pharma Plc Performance Analysis
Revenue Growth Rate
Annual and quarterly growth comparisonEarnings Per Share Growth Rate
Annual and quarterly EPS growth comparisonQuarterly Performance
Revenue
$0.00
-100.0%
Gross Profit
$3.25M
-31.7%
Gross Margin
0.00%
N/A
Market Cap
N/A
N/A
Market Cap/Employee
N/A
N/A
Employees
20
N/A
Net Income
$2.42M
+47.3%
EBITDA
$4.93M
-32.7%
Quarterly Fundamentals
Net Cash
$512.00K
-76.9%
Accounts Receivable
$715.00K
+117.3%
Inventory
$0.00
N/A
Long Term Debt
$118.00K
-74.5%
Short Term Debt
$1.04M
+545.3%
Return on Assets
-35.09%
N/A
Return on Invested Capital
-72.66%
N/A
Free Cash Flow
$8.23M
-132.6%
Operating Cash Flow
$7.45M
-112.4%